MINNEAPOLIS, Aug. 16, /PRNewswire-FirstCall/ -- Uroplasty,
Inc. (Nasdaq: UPI), a medical device company that develops,
manufactures and markets innovative proprietary products to treat
voiding dysfunctions, announced today that David Kaysen, Uroplasty's President and CEO, and
Medi Jiwani, Uroplasty's Vice
President and CFO, will present the Company's business strategy and
financial results at the Global Hunter Securities Inaugural
Healthcare Conference at 3:30 PM PDT on Tuesday, August 17, 2010 at The Island Hotel
in Newport Beach,
California.
Attendance at the conference is by invitation only. A live
audio-only webcast of the presentation will be broadcast via the
Internet. Those interested in listening to the webcast may
access it at
http://events.powerstream.net/002/00271/20100817_SCIC_T3/, or
through Uroplasty's website at www.uroplasty.com.
About Uroplasty, Inc.
Uroplasty, Inc., headquartered in Minnetonka, Minnesota, with wholly-owned
subsidiaries in
The Netherlands and the
United Kingdom, is a medical
device company that develops, manufactures and markets innovative
proprietary products for the treatment of voiding dysfunctions. Our
focus is the continued commercialization of our Urgent PC system,
which we believe is the only FDA-approved minimally invasive nerve
stimulation device designed for office-based treatment of urinary
urgency, urinary frequency and urge incontinence – symptoms often
associated with overactive bladder.
We also offer Macroplastique Implants, an injectable urethral
bulking agent for the treatment of adult female stress urinary
incontinence primarily due to intrinsic sphincter deficiency. For
more information on the company and its products, please visit
Uroplasty, Inc. at www.uroplasty.com.
|
|
For Further
Information:
Uroplasty, Inc.
David Kaysen, President and CEO,
or
Medi Jiwani, Vice President,
CFO, Treasurer
952.426.6140
|
EVC Group
Doug Sherk (Investors),
415.896.6820
Chris Gale (Media),
646.201.5431
|
|
|
|
|
|
SOURCE Uroplasty, Inc.
Copyright . 16 PR Newswire